1: Global burden of diabetes and depression,
2: A lifecourse approach to understanding the association between depression and type 2 diabetes,
3: MicroRNAs as novel biomarkers in depression, diabetes and cardiovascular diseases,
5: Innate immunity and inflammation in type 2 diabetes-associated depression,
6: Hypothalamic-Pituitary-Adrenal (HPA) axis,
7: Gut-brain axis: physiology,
8: Diabetes distress,
9: The association between depression and cognitive impairment in type 2 diabetes,
10: Treatment of depression in type 2 diabetes,
11: Risks and benefits of psychotropics,
12: Metabolic surgery and depression,
13: Novel pharmacological targets,
14: Novel technologies,
15: Current and emerging psychological models,
16: Targeting the circadian rhythm,
17: Cultural and global perspectives,
18: National and international policy initiatives on multi-morbidity,
Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally.
Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes.
Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.
• Written and edited by a team of internationally recognized clinicians
• Offers a unique perspective on the outstanding controversies of the epidemiology, mechanisms and treatment of the depression-type 2 diabetes comorbidity
• Khalida Ismail, Professor of Psychiatry and Medicine, Department of Psychological Medicine Institute of Psychiatry, Psychology and Neuroscience King's College London, London, UK.
• Andreas Barthel, Associate Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Medicover Bochum, Germany.
• Stefan R. Bornstein, Professor of Medicine, Department of Medicine, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, Germany School of Life Course Sciences, Department of Diabetes, King's College London, London, UK.
• Julio Licinio, Deputy Director, College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA